Treatment should be initiated at a dose of 62.5mg twice daily for four weeks and then increased to a maintenance dose of 125mg twice daily.
Further information: Actelion
Tracleer licence extension
23 May 2008, 2:48pm
The licence for Tracleer (bosentan) has been extended to include use for the reduction of the number of new digital ulcers in patients with systemic sclerosis and ongoing digital ulcer disease.
MIMs Drug Search
Possible searches include drugs (by brand, generic ingredient or drug class), diseases and more.
